A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of DFN-02 in Episodic Migraine With or Without Aura
Latest Information Update: 31 Mar 2021
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 15 Mar 2019 Results published in the CNS Drugs
- 01 May 2018 Results published in the Headache
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology